The impact of a co-payment on the cost-effectiveness of screening for diabetic retinopathy

J Public Health (Oxf). 2016 Dec 2;38(4):782-792. doi: 10.1093/pubmed/fdv168.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cost-Benefit Analysis
  • Diabetic Retinopathy / diagnosis*
  • Diabetic Retinopathy / economics*
  • Health Care Costs*
  • Humans
  • Mass Screening / economics*